- Home
- SDHC vs SXTC Comparison
SDHC vs SXTC Comparison
Compare SDHC & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDHC | SXTC |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.7M | 177.7M |
| IPO Year | 2024 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SDHC | SXTC |
|---|---|---|
| Price | $17.50 | $1.51 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $16.70 | N/A |
| AVG Volume (30 Days) | ★ 79.3K | 72.4K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $998,173,000.00 | $1,740,907.00 |
| Revenue This Year | $0.60 | N/A |
| Revenue Next Year | $7.10 | N/A |
| P/E Ratio | $80.24 | ★ N/A |
| Revenue Growth | ★ 10.26 | N/A |
| 52 Week Low | $15.00 | $0.95 |
| 52 Week High | $27.69 | $7.84 |
Technical Indicators
Market Signals| Indicator | SDHC | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 39.13 | 53.79 |
| Support Level | $19.48 | $1.52 |
| Resistance Level | $20.93 | $1.61 |
| Average True Range (ATR) | 1.25 | 0.08 |
| MACD | -0.48 | 0.01 |
| Stochastic Oscillator | 8.34 | 37.21 |
Price Performance
Historical ComparisonAbout SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.